Literature DB >> 7599632

Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.

E M Algar1, M T Kenney, L A Simms, S I Smith, Y Kida, P J Smith.   

Abstract

We have examined a panel of 21 sporadic Wilms' tumours for rearrangements in the Wilms' tumour suppressor gene, WT1. In one tumour with specific allele loss in chromosome 11p13, a homozygous deletion in the 3' end of the gene, encompassing exon 10 and the 3' untranslated region, was identified. High levels of a truncated WT1 transcript, predicted to encode a polypeptide missing the fourth zinc finger were expressed in this tumour. All other samples showed normal patterns of digestion on Southern blots. This observation confirms previous findings that large deletions in the gene occur infrequently in sporadic Wilms' tumours and that the zinc-finger region of the encoded polypeptide is critical for correct functioning of the gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599632     DOI: 10.1002/humu.1380050306

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  5 in total

Review 1.  Wilms' tumor gene WT1: its oncogenic function and clinical application.

Authors:  H Sugiyama
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

2.  CDKN1C expression in Beckwith-Wiedemann syndrome patients with allele imbalance.

Authors:  E M Algar; G J Deeble; P J Smith
Journal:  J Med Genet       Date:  1999-07       Impact factor: 6.318

Review 3.  Cancer immunotherapy targeting WT1 protein.

Authors:  Haruo Sugiyama
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

4.  Dysregulation of gene expression in the artificial human trisomy cells of chromosome 8 associated with transformed cell phenotypes.

Authors:  Hisakatsu Nawata; Genro Kashino; Keizo Tano; Kazuhiro Daino; Yoshiya Shimada; Hiroyuki Kugoh; Mitsuo Oshimura; Masami Watanabe
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

Review 5.  Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers.

Authors:  Md Emranul Karim; Kyi Kyi Tha; Iekhsan Othman; Mohammad Borhan Uddin; Ezharul Hoque Chowdhury
Journal:  Pharmaceutics       Date:  2018-05-26       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.